Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RGEN
#901
Repligen Corporation - Common Stock
175.4
2
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.69%
Monthly Change
+5.21%
6 month change
+41.34%
Year Change
+5.87%
Previous Close
172.5
1
Open
172.5
1
Low
169.7
3
High
177.9
6
Markets
US Stock Market
Healthcare
Medical Instruments & Supplies
RGEN
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
54.77 M
55.33 M
55.56 M
55.77 M
56.15 M
56.33 M
56.44 M
Valuation ratios
Enterprise value
9.78 B
14.05 B
8.48 B
9.83 B
7.85 B
8.66 B
8.41 B
Price to earnings ratio
172.64
118.23
50
242.28
-312.91
190.53
215.79
Price to sales ratio
28.2
22.62
0.01
0.02
0.01
0.01
—
Price to cash flow ratio
164.91
127.43
0.05
0.09
0.05
0.08
0.12
Price to book ratio
6.75
8.67
0
0.01
0
0
0
Enterprise value to EBITDA ratio
90.72
64.66
30.55
78.54
156.46
57.53
—
Profitability ratios
Return on assets %
0.03
0.05
0.07
0.01
-0.01
0.02
0
Return on equity %
0.04
0.07
0.1
0.02
-0.01
0.02
0
Return on invested capital %
26.58
38.03
43.3
7.38
-6.66
9.24
1.08
Gross margin %
57.23
58.35
56.85
44.59
43.29
52.32
53.91
Operating margin %
19.06
24.94
28.03
8.54
-5.53
7.47
6.85
EBITDA margin %
29.43
32.4
34.62
19.59
7.91
20.4
13.69
Net margin %
16.36
19.13
23.2
6.51
-4.02
6.62
2.45
Liquidity ratios
Quick ratio
2.53
1.99
1.88
5.75
7.28
7.12
7.64
Current ratio
2.83
2.48
2.47
7.02
8.41
8.37
9.05
Inventory turnover
2.09
2
1.64
1.61
2.08
2.07
0.5
Asset turnover
0.22
0.31
0.33
0.24
0.22
0.25
0.07
Solvency ratios
Debt to assets ratio
—
—
—
0.21
0.19
—
—
Debt to equity ratio
—
—
—
0.29
0.27
—
—
Long term debt to total assets ratio
0.13
0.11
0.11
0.21
0.19
0.18
0.19
Long term debt to total equity ratio
0.16
0.15
0.15
0.29
0.27
0.26
0.26
Per share metrics
Operating cash flow per share
1.16
2.08
2 995.09
2 020.65
3 135.56
2 075.94
1 306.35
EBIT per share
1.3
2.92
3 910.36
968.05
-627.74
975.35
614.05
EBITDA per share
2
3.79
4 829.61
2 219.42
896.97
2 662.84
1 495.69
Total debt per share
—
—
—
10.28 K
9 395.7
—
—
Cash per share
13.31
10.54
10.86 K
13.33 K
13.54 K
17.14 K
17.91
Net current asset value per share
16.74
16.27
17.37 K
19.71 K
19.06 K
20.11 K
21.2
Tangible book value per share
28.37
30.56
33.26 K
34.96 K
35.27 K
37.24 K
37.29
Working capital per share
10.83
9.72
10.34 K
16.9 K
16.79 K
17.71 K
18.85
Book value per share
28.37
30.56
33.26 K
34.96 K
35.27 K
37.24 K
37.29
News
Barclays Maintains Overweight on Repligen, Raises Price Target to $225
New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector - TipRanks.com
Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study
Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290
JNJ's Caplyta Shows Benefit in Bipolar 1 Related Mania Study
10 Health Care Stocks Whale Activity In Today’s Session
NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
Merck Gets CHMP Backing for Keytruda-Padcev Combo in Bladder Cancer
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins
RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma Study